高级检索

    意义不止当下,路漫漫其修远: 评纳武利尤单抗联合XELOX/FOLFOX方案在HER2阴性晚期胃癌一线治疗中的应用和影响

    Meaningful, but Still a Long Way to Go: Comment on the Application and Influence of Nivolumab Combined With XELOX/FOLFOX in the First-Line Treatment of HER2-Negative Advanced Gastric Cancer

      摘要
      • HTML全文
      • 参考文献(5)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回